Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HC Surgical SpecialistsSGX:1B1 -2.86%63 Altman Z-Score is 5.30 as of Aug. 25, 2026, which is 8% above its 10-year median of 4.90. GuruFocus rates SGX:1B1 with a GF Score™ of 63/100 and a GF Value™ of S$0.30 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, HC Surgical Specialists ranks better than 73.27% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 5.26 is strong.
HC Surgical Specialists has a Altman Z-Score of 5.30, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for HC Surgical Specialists's Altman Z-Score or its related term are showing as below:
SGX:1B1'
s Altman Z-Score Range Over the Past 10 Years
Min: 3.56 Med: 4.9 Max: 32.98
Current: 5.26
During the past 13 years, HC Surgical Specialists's highest Altman Z-Score was 32.98. The lowest was 3.56. And the median was 4.90.
HC Surgical Specialists (SGX:1B1) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:1B1 vs TMO, DHR, IDXX: Altman Z-Score Comparison
For the Diagnostics & Research subindustry, HC Surgical Specialists's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HC Surgical Specialists Altman Z-Score vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, HC Surgical Specialists's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where HC Surgical Specialists's Altman Z-Score falls into.
HC Surgical Specialists Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
HC Surgical Specialists (SGX:1B1) has a Altman Z-Score of 5.30 as of Aug. 25, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on HC Surgical Specialists and its competitors. This is near median its historical median of 4.90. Over the past decade, HC Surgical Specialists' Altman Z-Score has ranged from 3.56 to 32.98. According to the industry distribution chart, HC Surgical Specialists ranks #54 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 26.7%.
Is HC Surgical Specialists' Altman Z-Score too high?
HC Surgical Specialists' current Altman Z-Score of 5.30 is near median its 10-year median of 4.90. Over the past 10 years, this metric has ranged from a low of 3.56 to a high of 32.98. The Medical Diagnostics & Research industry median Altman Z-Score is 2.47. HC Surgical Specialists' value of 5.30 is 114.6% above this industry median. Based on the distribution chart, HC Surgical Specialists ranks #54 out of 202 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, HC Surgical Specialists has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HC Surgical Specialists' Altman Z-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, HC Surgical Specialists ranks #54 out of 202 companies for Altman Z-Score. This puts HC Surgical Specialists in the upper half of its industry. The industry median Altman Z-Score is 2.47. HC Surgical Specialists' value of 5.30 is 114.6% above this benchmark. Historically, HC Surgical Specialists' own Altman Z-Score has ranged from 3.56 to 32.98 over the past decade. While the company's 10-year median is 4.90 vs. the industry median of 2.47, HC Surgical Specialists has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Diagnostics & Research company?
The median Altman Z-Score among Medical Diagnostics & Research companies is 2.47, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HC Surgical Specialists's current Altman Z-Score of 5.30 is 114.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on HC Surgical Specialists and its competitors. For the Medical Diagnostics & Research industry, the median Altman Z-Score is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HC Surgical Specialists's current Altman Z-Score is 5.30, which is near median its own 10-year median of 4.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HC Surgical Specialists stock overvalued right now?
Based on GuruFocus' analysis, HC Surgical Specialists (SGX:1B1) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.30, compared to a current price of S$0.34 — trading 13.3% above its estimated fair value. The current Altman Z-Score is 5.30, which is near median its 10-year median of 4.90 and 114.6% above the Medical Diagnostics & Research industry median of 2.47. HC Surgical Specialists' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For HC Surgical Specialists (SGX:1B1), the current Altman Z-Score is 5.30 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HC Surgical Specialists (SGX:1B1) Overvalued in 2026?
Based on GuruFocus' analysis, HC Surgical Specialists stock appears to be overvalued.
The current stock price of S$0.34 is trading 13.3% above its estimated GF Value™ of S$0.30.
GuruFocus considers HC Surgical Specialists to be Modestly Overvalued.
Key valuation signals for SGX:1B1:
Altman Z-Score: 5.30 (near median its 10-year median of 4.90)
GF Value™: S$0.30 vs. price of S$0.34 (13.3% above fair value)
Industry Position: 114.6% above the Medical Diagnostics & Research median (#54 of 202)
No single metric tells the full story. See the SGX:1B1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HC Surgical Specialists Ltd is a medical services group. The company is engaged in providing endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The operating segment of the company is the healthcare segment. Geographically, it operates only in Singapore. The company has its facilities center and clinics at various places in Singapore.
63GF Score
Get the complete analysis for SGX:1B1
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1B1 has been successfully added to your 
